Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
947.35B
Market cap947.35B
Price-Earnings ratio
36.56
Price-Earnings ratio36.56
Dividend yield
0.61%
Dividend yield0.61%
Average volume
4.03M
Average volume4.03M
High today
$1,021.49
High today$1,021.49
Low today
$996.01
Low today$996.01
Open price
$1,017.37
Open price$1,017.37
Volume
1.05M
Volume1.05M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,005.96, giving the company a market capitalization of 947.35B. It carries a P/E multiple of 36.56 and pays a dividend yield of 61.3%.

On 2026-05-14, Eli Lilly(LLY) stock traded between a low of $996.01 and a high of $1,021.49. Shares are currently priced at $1,005.96, which is +1.0% above the low and -1.5% below the high.

The Eli Lilly(LLY)'s current trading volume is 1.05M, compared to an average daily volume of 4.03M.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

LLY News

24/7 Wall St. 1h
Is Eli Lilly Going To $1,100?

Is Eli Lilly Going To $1,100? By Vandita Jadeja Published May 14, 1:34PM EDT Quick Read Eli Lilly (LLY) reported Q1 2026 revenue of $19.799B, beating consensu...

Is Eli Lilly Going To $1,100?
TipRanks 2h
Eli Lilly’s New Alopecia Drug Trial Moves Forward, Expanding Its Immunology Pipeline

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...

TipRanks 2h
Lilly Tests Dual Psoriatic Arthritis and Obesity Strategy With Ixekizumab–Tirzepatide Combo

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
12.1%
Sell
3%

More LLY News

TipRanks 6h
Eli Lilly, Unicef announce collaboration

Eli Lilly (LLY) and Company and UNICEF USA announced a collaboration aiming to improve non-communicable disease prevention and care for children, reaching over...

Nasdaq 9h
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?

Key Points In the recent quarter, Lilly’s weight loss portfolio generated more than $12 billion in sales. The company's longtime competitor is Novo Nordisk, m...

Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?
Benzinga 1d
Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss

• Eli Lilly stock is showing upward bias. What should traders watch with LLY? The company presented data from the SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN studies...

Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss
Benzinga 1d
Eli Lilly's Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss - Eli Lilly - Benzinga

...

Eli Lilly's Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss - Eli Lilly - Benzinga
Barron's 1d
Micron Is About to Make Its Own History

Micron Is About to Make Its Own History Micron Technology is on pace to close above the $900 billion market value for the first time, according to Dow Jones Ma...

Micron Is About to Make Its Own History
Seeking Alpha 1d
Eli Lilly Alzheimer's drug donanemab launched in India

Eli Lilly (LLY) on Wednesday rolled out its Alzheimer’s therapy donanemab under the brand name Lormalzi in India, where the percentage of patients affected by t...

Eli Lilly Alzheimer's drug donanemab launched in India
Simply Wall St 1d
Eli Lilly Marks 150 Years With Food Security Drive And Investor Angles

Eli Lilly is marking its 150th anniversary with a large food security initiative in the United States. The company plans to help distribute 500,000 meals and f...

Eli Lilly Marks 150 Years With Food Security Drive And Investor Angles

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.